MED7 and neoplasm: It was hypothesised that low-grade BCs develop through a different pathway from high-grade tumours that may involve alterations in the expression of ER and altered genetic profiles in low-grade compared with high-grade tumours.42 This could implicate MED7 as having a putative role in low-grade ER+ tumourigenic pathways.